James Cook University, Queensland, Australia
8
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
12.5%
1 terminated/withdrawn out of 8 trials
87.5%
+1.0% vs industry average
13%
1 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Safe and Well Visits by the Fire and Rescue Service to Prevent Falls and Improve Quality of Life in Older People
Role: collaborator
Antimicrobial Stewardship Program (ASP) in Patients With a Sore Throat
Role: collaborator
ESWT as a Treatment for Chronic NHO in TBI Patients
Role: collaborator
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
Role: collaborator
Hookworm Therapy for Coeliac Disease
Role: lead
Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity
Role: collaborator
Volar Locking Plate Versus External Fixator/Cast Fixation for the Treatment of Distal Radius Fractures
Role: collaborator
China Salt Substitute Study
Role: collaborator
All 8 trials loaded